{"version":"1.0","provider_name":"Journal of Medical Ethics blog","provider_url":"https:\/\/blogs.bmj.com\/medical-ethics","author_name":"owenschaefer","author_url":"https:\/\/blogs.bmj.com\/medical-ethics\/author\/owenschaefer\/","title":"Placebos and ethics in digital therapeutics - Journal of Medical Ethics blog","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"rrXH1LLMXS\"><a href=\"https:\/\/blogs.bmj.com\/medical-ethics\/2026\/01\/27\/placebos-and-ethics-in-digital-therapeutics\/\">Placebos and ethics in digital therapeutics<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/blogs.bmj.com\/medical-ethics\/2026\/01\/27\/placebos-and-ethics-in-digital-therapeutics\/embed\/#?secret=rrXH1LLMXS\" width=\"600\" height=\"338\" title=\"&#8220;Placebos and ethics in digital therapeutics&#8221; &#8212; Journal of Medical Ethics blog\" data-secret=\"rrXH1LLMXS\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/blogs.bmj.com\/medical-ethics\/wp-includes\/js\/wp-embed.min.js\n\/* ]]> *\/\n<\/script>\n","description":"By Jacqueline Lutz &amp; Lindsay Ayearst In applied digital health, questions about evidence generation are inseparable from how products are built and whether they ever reach patients. Many scientists working on digital therapeutics are academically trained to run controlled clinical studies, behavioral experiments, or to study specific behavioral intervention mechanisms. That rigor does not disappear [...]Read More..."}